Boyett Health Services

Hamilton, Alabama 35570

0 studies enrolling now · 6 studies all time

What they study most

Cardiovascular Disease, Opioid Dependence, Opioid Related Disorders, Opioid Use Disorder, Opioid-related Disorders, Opioid-use Disorder

Studies at this site

• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery — Completed
• Open-Label Treatment Extension Study — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder — Completed
• Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine — Completed